ARCH Venture Fund VII, L.P., 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), sold 329,166 shares at $6.87 ($2.2M) on 2019-03-07, disclosed to the SEC on 2019-03-11.
Open-market sale of $2.2M SYRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.87 | 35,209 | $242K | 10.8% |
| 2 | $6.87 | 35,209 | $242K | 10.8% |
| 3 | $6.93 | 84,496 | $586K | 26.2% |
| 4 | $6.93 | 84,496 | $586K | 26.2% |
| 5 | $6.49 | 44,878 | $291K | 13.0% |
| 6 | $6.49 | 44,878 |
| $291K |
| 13.0% |
| Total | $6.80 avg | 329,166 | $2.2M | 100% |